Integrated Diagnostics Holdings Plc

Integrated Diagnostics (IDHC)

Company name:Integrated Diagnostics Holdings Plc
EPIC:IDHCTrading Currency:USD
Market Sector:SMEVISIN:JE00BV9H9G76
Market Segment:SSMUShare Type:DE
WWW Address:http://www.idhcorp.com/Description:ORD USD1.00
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 4.64 uk.advfn.com/p.php?gfx=/gb/down -0.005 [-0.11] 4.62 4.65 4.65 4.65 4.62 10,868
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 695.77 150.11 -0.00 16.04 - 28.89 - 5.20 - 3.30

Integrated Diagnostics Key Figures

(at previous day's close)
Market Cap.695.77m
Shares In Issue150.11m
Prev. Close4.64
PE Ratio28.89 
Dividend Yield-%
EPS - basic16.04¢($)
Dividend PS-¢($)
Dividend Cover- 
Cash Flow PS16.24¢($)
Return On Equity (ROE)22.12%
Operating Margin37.33%
PEG Factor0.84 
EPS Growth Rate34.54%
Dividends PS Growth Rate-%
Net Debt26.67m
Gross Gearing30.09%
Quick Assets31.75m
Net Working Capital6.41m
Intangibles / Fixed Assets63.88%
Turnover PS56.08¢($)
Pre-Tax Profit PS20.94¢($)
Retained Profit PS1.96¢($)
Cash PS12.39¢($)
Net Cash PS-7.14¢($)
Net Tangible Asset Value PS *17.44¢($)
Net Asset Value PS70.07¢($)
Spread0.03 (0.65%) 

Integrated Diagnostics Balance Sheet

LSE:IDHC:Liabilities+EQLSE:IDHC:Assets

Share Price Performance

Sample Period HighLow
1 week4.944.60
4 weeks4.944.28
12 weeks5.204.28
1 year5.203.30

Share Price Chart (5 years)

Integrated Diagnostics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week4.600.040.764.600.004.63
4 weeks4.85-0.22-4.434.280.024.65
12 weeks4.90-0.27-5.414.280.064.79
26 weeks5.00-0.37-7.304.280.064.84
1 year3.800.8421.973.300.094.41
3 years2.951.6957.122.200.074.06
5 years5.05-0.42-8.222.200.104.73

Integrated Diagnostics Key Management Ratios

Integrated Diagnostics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio31.72 
PE Ratio28.89 
Tobin's Q Ratio 0.21 
Tobin's Q Ratio (excl. intangibles)0.43 
Dividend Yield-%
Market-to-Book Ratio7.00 
Price-to-Pre-Tax Profit PS22.14 
Price-to-Retained Profit PS236.52 
Price-to-Cash Flow PS28.54 
Price-to-Sales PS8.26 
Price-to-Net Tangible Asset Value PS21.81 
Price-to-Cash PS37.40 
Net Working Capital PS4.27 
Price Pct to Working Capital PS108.52%
Earnings Yield3.46%
Average PE0.03 
Years in average4 
PE to PE average114,117.48%

Integrated Diagnostics Financial Ratios

(Leverage Ratios)
Debt Ratio13.16%
Debt-to-Equity Ratio0.15 
Debt-to-Equity Ratio (excl. Intgbl)0.50 
Debt-to-Equity Market Value0.02 
Net Gearing17.72%
Net Gearing (excl. Intangibles)34.55%
Gross Gearing30.09%
Gross Gearing (excl. Intangibles)58.66%
Gearing Under 1 Year19.49%
Gearing Under 1 Year (excl. Intgbl)38.00%
Assets/Equity1.43 
Cash/Equity17.69 
(Liquidity Ratios)
Net Working Capital to Total Assets4.26%
Current Ratio1.22 
Quick Ratio (Acid Test)1.08 
Liquidity Ratio0.63 
Cash & Equiv/Current Assets52.05%
(Solvency Ratios)
Enterprise Value698.83m
CFO/Sales0.29 
CFO/Attributable Profit1.11 
CFO/Assets0.16 
CFO/Debt0.54 
Total Debt/Equity Market Value0.07 
Total Debt/Sales0.54 
Total Debt/Pre-Tax Profit1.44 
Total Debt45.27m
Total Debt/Net Current Assets7.06%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth24.40%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
-0.00100.0017

Integrated Diagnostics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)25.95%
Return On Assets (ROA)0.67%
Net Profit Margin26.13%
Assets Turnover0.03 
Return On Equity (ROE)22.12%
Return On Investment (ROI)0.82%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio0.97%
Net Income Of Revenues3.49%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.04 
Fixed Assets Turnover0.04 
Current Assets Turnover0.09 
Net Working Capital Turnover 
Inventory Turnover1.05 
(Other Operating Ratios)
Total Assets-to-Sales38.87 
Debtors-to-Sales298.28%
Debt Collection Period1,088.72Days

Integrated Diagnostics Dividends

Sorry No Data Available

Integrated Diagnostics Fundamentals

 31 Dec 2015 (EGP)31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)
turnover1,014.84100.00%1,170.62100.00%1,514.26100.00%1,921.45100.00%m
pre tax profit274.4927.05%388.5433.19%558.4336.88%717.3637.33%m
attributable profit144.8714.28%260.4022.24%374.0224.70%502.0926.13%m
retained profit144.8714.28%260.4022.24%-2.72-0.18%67.143.49%m
eps - basic97.00 174.00 249.00 335.00 
eps - diluted97.00 174.00 249.00 335.00 
dividends per share- - - - 

Integrated Diagnostics Balance Sheet

 31 Dec 2015 (EGP)31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)
LSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:Assets
 31 Dec 2015 (EGP)31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)
ASSETS
fixed assets fixed assets337.8813.61%391.1412.84%473.7915.23%705.7820.55%m
intangibles intangibles1,606.2364.68%1,643.6053.96%1,658.2553.29%1,672.4648.71%m
fixed investments fixed investments--%95.583.14%9.150.29%239.906.99%m
current assets - other current assets - other--%--%--%--%m
stocks stocks34.331.38%51.721.70%69.942.25%91.082.65%m
debtors debtors117.164.72%166.685.47%202.266.50%299.998.74%m
cash & securities cash & securities387.7215.61%696.9722.88%698.4422.44%424.5712.36%m
TOTAL2,483.30100%3,045.68100%3,111.81100%3,433.79100%m
LIABILITIES
creditors - short creditors - short341.1113.74%481.7515.82%485.4115.60%669.3219.49%m
creditors - long creditors - long199.728.04%264.478.68%312.3110.04%363.8310.60%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL540.8321.78%746.2224.50%797.7225.64%1,033.1530.09%m
EQUITY
ord cap, reserves ord cap, reserves1,895.6076.33%2,237.3073.46%2,245.5972.16%2,270.0566.11%m
prefs, minorities prefs, minorities46.871.89%62.162.04%68.502.20%130.593.80%m
TOTAL1,942.4778.22%2,299.4675.50%2,314.0974.36%2,400.6469.91%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Integrated Diagnostics Cash Flow Statement

31 Dec 2015 (EGP)31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)
Operating CF189.86398.66403.08556.31m
Pre-Financing CF147.44261.13369.1890.69m
Retained CF134.68142.93-1.64-268.04m

Integrated Diagnostics Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
IDHC
Integrated..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191020 01:46:42